Paper28348451
Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases.
Ying S and 15 others. Dis Markers, 2017. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. Serum HMGB1 as a Potential Biomarker for Patients with Asbestos-Related Diseases. Papers, record 28348451. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28348451
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Asbestosis | Major topic |
| Biomarkers, Tumor | Major topic |
| HMGB1 Protein | Major topic |
| Lung Neoplasms | Major topic |
| Mesothelioma | Major topic |
| Aged | |
| Case-Control Studies | |
| Female | |
| Humans | |
| Male | |
| Matrix Metalloproteinase 2 | |
| Matrix Metalloproteinase 9 | |
| Mesothelioma, Malignant | |
| Middle Aged |
Source PubMed
References48
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25030441 | Serum high mobility group box protein 1 as a clinical marker for ovarian cancer. | Neoplasma | 2014 | https://conductscience.org/library/papers/25030441 | PubMed |
| 2 | 22428766 | HMGB1 and its physiological and pathological roles. | Bratisl Lek Listy | 2012 | https://conductscience.org/library/papers/22428766 | PubMed |
| 3 | 17275314 | Matrix metalloproteinases (MMPs): chemical-biological functions and (Q)SARs. | Bioorg Med Chem | 2007 | https://conductscience.org/library/papers/17275314 | PubMed |
| 4 | 27348219 | HMGB1 Is a Potential Biomarker for Severe Viral Hemorrhagic Fevers. | PLoS Negl Trop Dis | 2016 | https://conductscience.org/library/papers/27348219 | PubMed |
| 5 | 26308799 | Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies. | Expert Rev Respir Med | 2015 | https://conductscience.org/library/papers/26308799 | PubMed |
| 6 | 20192808 | HMGB1 and RAGE in inflammation and cancer. | Annu Rev Immunol | 2010 | https://conductscience.org/library/papers/20192808 | PubMed |
| 7 | 15753486 | Diagnosis and initial management of nonmalignant diseases related to asbestos. | Am J Respir Crit Care Med | 2005 | https://conductscience.org/library/papers/15753486 | PubMed |
| 8 | 22552293 | Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. | Cancer Res | 2012 | https://conductscience.org/library/papers/22552293 | PubMed |
| 9 | 25275029 | Prognostic significance of high mobility group box 1 (HMGB1) expression in patients with colorectal cancer. | Anticancer Res | 2014 | https://conductscience.org/library/papers/25275029 | PubMed |
| 10 | 25004875 | Baicalein inhibits HMGB1 release and MMP-2/-9 expression in lipopolysaccharide-induced cardiac hypertrophy. | Am J Chin Med | 2014 | https://conductscience.org/library/papers/25004875 | PubMed |
| 11 | 22065079 | Molecular pathways: targeting mechanisms of asbestos and erionite carcinogenesis in mesothelioma. | Clin Cancer Res | 2012 | https://conductscience.org/library/papers/22065079 | PubMed |
| 12 | 21487520 | Paradoxical function for the receptor for advanced glycation end products in mouse models of pulmonary fibrosis. | Int J Clin Exp Pathol | 2011 | https://conductscience.org/library/papers/21487520 | PubMed |
| 13 | 24160326 | Continuous exposure to chrysotile asbestos can cause transformation of human mesothelial cells via HMGB1 and TNF-α signaling. | Am J Pathol | 2013 | https://conductscience.org/library/papers/24160326 | PubMed |
| 14 | 20616036 | Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/20616036 | PubMed |
| 15 | 26305032 | Clinical impact of high mobility group box 1 protein in epithelial ovarian cancer. | Arch Gynecol Obstet | 2016 | https://conductscience.org/library/papers/26305032 | PubMed |
| 16 | 22929121 | Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. | Arch Pathol Lab Med | 2013 | https://conductscience.org/library/papers/22929121 | PubMed |
| 17 | 26147229 | Asbestos textile production linked to malignant peritoneal and pleural mesothelioma in women: Analysis of 28 cases in Southeast China. | Am J Ind Med | 2015 | https://conductscience.org/library/papers/26147229 | PubMed |
| 18 | 22726320 | Elimination of asbestos use and asbestos-related diseases: an unfinished story. | Cancer Sci | 2012 | https://conductscience.org/library/papers/22726320 | PubMed |
| 19 | 24998555 | Expression of high mobility group box - B1 (HMGB-1) and matrix metalloproteinase-9 (MMP-9) in non-small cell lung cancer (NSCLC). | Asian Pac J Cancer Prev | 2014 | https://conductscience.org/library/papers/24998555 | PubMed |
| 20 | 26733616 | HMGB1 and Its Hyperacetylated Isoform are Sensitive and Specific Serum Biomarkers to Detect Asbestos Exposure and to Identify Mesothelioma Patients. | Clin Cancer Res | 2016 | https://conductscience.org/library/papers/26733616 | PubMed |
Cited by28
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42737756 | Damage-Associated Molecular Patterns in Mesothelioma: Drivers of Inflammation and Therapeutic Targets. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737756 | PubMed |
| 41375064 | Circulating Biomarkers and Targeted Therapy in Pleural Mesothelioma. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41375064 | PubMed |
| 40559922 | HMGB1 as a Key Mediator in Malignant Mesothelioma and a Potential Target for Asbestos-Related Cancer Therapy. | Toxics | 2025 | https://conductscience.org/library/papers/40559922 | PubMed |
| 39400573 | Biomarkers Suitable for Early Detection of Intrathoracic Cancers in Primary Care: A Systematic Review. | Cancer Epidemiol Biomarkers Prev | 2025 | https://conductscience.org/library/papers/39400573 | PubMed |
| 38002620 | Pleural Mesothelioma: Advances in Blood and Pleural Biomarkers. | J Clin Med | 2023 | https://conductscience.org/library/papers/38002620 | PubMed |
| 37626858 | Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma. | Cells | 2023 | https://conductscience.org/library/papers/37626858 | PubMed |
| 37545218 | Longitudinal monitoring of response to chemotherapy in patients with malignant pleural mesothelioma by biomarkers. | Cancer Biomark | 2023 | https://conductscience.org/library/papers/37545218 | PubMed |
| 37095543 | ATG5 as biomarker for early detection of malignant mesothelioma. | BMC Res Notes | 2023 | https://conductscience.org/library/papers/37095543 | PubMed |
| 36644178 | Serum diagnostic markers for malignant pleural mesothelioma: a narrative review. | Transl Cancer Res | 2022 | https://conductscience.org/library/papers/36644178 | PubMed |
| 36475505 | Identification of a new potential plasmatic biomarker panel for the diagnosis of malignant pleural mesothelioma. | Med Lav | 2022 | https://conductscience.org/library/papers/36475505 | PubMed |
| 35978837 | Mortality due to respiratory system disease and lung cancer among female workers exposed to chrysotile in Eastern China: A cross-sectional study. | Front Oncol | 2022 | https://conductscience.org/library/papers/35978837 | PubMed |
| 35449069 | Assessment of the toxicity and carcinogenicity of double-walled carbon nanotubes in the rat lung after intratracheal instillation: a two-year study. | Part Fibre Toxicol | 2022 | https://conductscience.org/library/papers/35449069 | PubMed |
| 35098108 | Asbestos-induced chronic inflammation in malignant pleural mesothelioma and related therapeutic approaches-a narrative review. | Precis Cancer Med | 2021 | https://conductscience.org/library/papers/35098108 | PubMed |
| 34789461 | Clinical utility of diagnostic biomarkers in malignant pleural mesothelioma: a systematic review and meta-analysis. | Eur Respir Rev | 2021 | https://conductscience.org/library/papers/34789461 | PubMed |
| 34630581 | Protective Effect of an Anti-HMGB-1 Neutralizing Antibody on Hemozoin-Induced Alveolar Epithelial Cell in a Model of Malaria Associated ALI/ARDS. | Iran J Parasitol | 2021 | https://conductscience.org/library/papers/34630581 | PubMed |
| 33802313 | The Evolving Landscape of the Molecular Epidemiology of Malignant Pleural Mesothelioma. | J Clin Med | 2021 | https://conductscience.org/library/papers/33802313 | PubMed |
| 33230247 | Overexpression of fibulin-3 in tumor tissue predicts poor survival of malignant mesothelioma patients from hand-spinning asbestos exposed area in eastern China. | Sci Rep | 2020 | https://conductscience.org/library/papers/33230247 | PubMed |
| 33149905 | Update of in vitro, in vivo and ex vivo fluoro-edenite effects on malignant mesothelioma: A systematic review (Review). | Biomed Rep | 2020 | https://conductscience.org/library/papers/33149905 | PubMed |
| 32549782 | NLRP3 and CARD8 polymorphisms influence risk for asbestos-related diseases. | J Med Biochem | 2020 | https://conductscience.org/library/papers/32549782 | PubMed |
| 32363191 | Aberrant Expression of High Mobility Group Box Protein 1 in the Idiopathic Inflammatory Myopathies. | Front Cell Dev Biol | 2020 | https://conductscience.org/library/papers/32363191 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| AGER | 177 | PubTator's text mining | https://conductscience.org/library/genes/177 | NCBI Gene |
| HMGB1 | 3146 | PubTator's text mining | https://conductscience.org/library/genes/3146 | NCBI Gene |
| MMP2 | 4313 | PubTator's text mining | https://conductscience.org/library/genes/4313 | NCBI Gene |
| MMP9 | 4318 | PubTator's text mining | https://conductscience.org/library/genes/4318 | NCBI Gene |
| TNF | 7124 | PubTator's text mining | https://conductscience.org/library/genes/7124 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28348451
GET https://conductscience.org/api/papers/v1/28348451/references?page=2